当前位置: X-MOL 学术Cancer Discov. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Blood Monocyte Frequency May Be a Biomarker for Response to Anti–PD-1
Cancer Discovery ( IF 29.7 ) Pub Date : 2018-03-01 , DOI: 10.1158/2159-8290.cd-rw2018-016
American Association for Cancer Research

CD14+CD16HLA-DRhi monocyte frequency was linked to response to anti–PD-1 in patients with melanoma.



中文翻译:

血液单核细胞频率可能是抗PD-1反应的生物标志物

黑色素瘤患者的CD14 + CD16 - HLA-DR单核细胞频率与对抗PD-1的反应有关。

更新日期:2018-03-02
down
wechat
bug